Showing 151-160 of 3101 results for "".
The Prognostic Utility of Neurofilament Light Chain in Multiple Sclerosis: A Narrative Review
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-prognostic-utility-of-neurofilament-light-chain-in-multiple-sclerosis-a-narrative-review/32098/Neurofilament light chain has great promise as a prognostic biomarker in multiple sclerosis.The Multiple Sclerosis Prodrome: Past, Present, and Future
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-prodrome-past-present-and-future/31973/Multiple sclerosis may cause symptoms and disability prior to classically defined disease onset.The Best and Worst of Times?
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-best-and-worst-of-times/30206/Despite exciting advances in diagnosis and myriad treatments, clinical management for patients with multiple sclerosis remains challenging.Relapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.Integrative Care for Patients With Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/integrative-care-for-patients-with-multiple-sclerosis/30217/What is integrative care, and why should clinicians care about it?Editor's Message
https://practicalneurology.com/columns/practice-management/editors-message/30852/November/December 2015 Case Challenge: A 70-Year-Old Man with a Sudden Lisp
https://practicalneurology.com/diseases-diagnoses/neuromuscular/novemberdecember-2015-case-challenge-a-70-year-o/31086/By Mohanad Alzubaidi, MD and Aziz Shaibani, MD, FACP, FAAN, FANA A 70-year-old man presented with a six-month history of a "lisp," noted by his friends, that got worse the more he spoke. There was no diplopia, ptosis, dysphagia, muscle wasting, or extremities weakness. Since he was stresseOpportunities and Challenges in the Treatment of Pediatric-Onset Multiple Sclerosis with Highly Active Disease-Modifying Therapies
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/opportunities-and-challenges-in-the-treatment-of-pediatric-onset-multiple-sclerosis-with-highly-active-disease-modifying-therapies/32080/Clinical research aims to identify safer and more effective treatments for the overlooked population of children and adolescents with multiple sclerosis.- Expert Opinionhttps://practicalneurology.com/columns/practice-management/expert-opinion/31295/Management of Acute Seizures and Long-Term Antiepileptic Therapy: A Case StudyIn a recent article by Niranjan Siva, MD, and Amit Verma, MD, published in *Practical Neurology*, a 24-year-old male experienced two first-time generalized tonic-clonic seizures without aura within a two-hour period. Initi
Advances from ACTRIMS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/advances-from-actrims/30255/A single-track meeting creates more interaction opportunities that may lead to future advances.